ATNM
Price
$9.77
Change
-$0.00 (-0.00%)
Updated
May 17, 6:59 PM EST
72 days until earnings call
CYTK
Price
$59.53
Change
-$0.39 (-0.65%)
Updated
May 17, 6:59 PM EST
75 days until earnings call
Ad is loading...

ATNM vs CYTK

Header iconATNM vs CYTK Comparison
Open Charts ATNM vs CYTKBanner chart's image
Actinium Pharmaceuticals
Price$9.77
Change-$0.00 (-0.00%)
Volume$82.01K
CapitalizationN/A
Cytokinetics
Price$59.53
Change-$0.39 (-0.65%)
Volume$483.74K
CapitalizationN/A
View a ticker or compare two or three
ATNM vs CYTK Comparison Chart

Loading...

ATNMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATNM vs. CYTK commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a StrongSell and CYTK is a Hold.

COMPARISON
Comparison
May 18, 2024
Stock price -- (ATNM: $9.80 vs. CYTK: $59.53)
Brand notoriety: ATNM and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 44% vs. CYTK: 57%
Market capitalization -- ATNM: $291.88M vs. CYTK: $6.24B
ATNM [@Biotechnology] is valued at $291.88M. CYTK’s [@Biotechnology] market capitalization is $6.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $593.52B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 2 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 2 green, 3 red.
According to our system of comparison, CYTK is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while CYTK’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 5 bearish.
  • CYTK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATNM is a better buy in the short-term than CYTK.

Price Growth

ATNM (@Biotechnology) experienced а +12.26% price change this week, while CYTK (@Biotechnology) price change was -4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

ATNM is expected to report earnings on Jul 29, 2024.

CYTK is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATNM with price predictions.
OPEN
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($6.24B) has a higher market cap than ATNM($292M). ATNM YTD gains are higher at: 92.913 vs. CYTK (-28.698).
ATNMCYTKATNM / CYTK
Capitalization292M6.24B5%
EBITDAN/AN/A-
Gain YTD92.913-28.698-324%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ATNM vs CYTK: Fundamental Ratings
ATNM
CYTK
OUTLOOK RATING
1..100
1761
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
8831
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3647
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATNM's Valuation (92) in the Biotechnology industry is in the same range as CYTK (100). This means that ATNM’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (31) in the Biotechnology industry is somewhat better than the same rating for ATNM (88). This means that CYTK’s stock grew somewhat faster than ATNM’s over the last 12 months.

ATNM's SMR Rating (98) in the Biotechnology industry is in the same range as CYTK (100). This means that ATNM’s stock grew similarly to CYTK’s over the last 12 months.

ATNM's Price Growth Rating (36) in the Biotechnology industry is in the same range as CYTK (47). This means that ATNM’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ATNM (100). This means that CYTK’s stock grew significantly faster than ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMCYTK
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 1 day ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ATNMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BPTRX143.361.29
+0.91%
Baron Partners Retail
LSVVX14.630.04
+0.27%
LSV Conservative Value Equity
JACEX15.870.03
+0.19%
JHancock Mid Cap Growth R6
LSTOX12.83N/A
N/A
Lazard Global Strategic Equity Open
OMCIX41.05-0.02
-0.05%
Oberweis Micro Cap Institutional

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with ELVN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-0.51%
ELVN - ATNM
44%
Loosely correlated
-3.23%
LOGC - ATNM
43%
Loosely correlated
-0.90%
FUSN - ATNM
40%
Loosely correlated
+0.23%
XNCR - ATNM
37%
Loosely correlated
+2.54%
NTLA - ATNM
37%
Loosely correlated
+0.19%
More

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-0.65%
TVTX - CYTK
57%
Loosely correlated
-9.42%
VBIV - CYTK
44%
Loosely correlated
-3.02%
KRON - CYTK
43%
Loosely correlated
+3.89%
IOVA - CYTK
42%
Loosely correlated
-1.82%
DARE - CYTK
42%
Loosely correlated
+11.61%
More